243 related articles for article (PubMed ID: 16125817)
1. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
2. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
4. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
6. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
8. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
9. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
[TBL] [Abstract][Full Text] [Related]
10. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
11. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
[TBL] [Abstract][Full Text] [Related]
12. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis.
Cottard V; Mulleman D; Bouille P; Mezzina M; Boissier MC; Bessis N
Gene Ther; 2000 Nov; 7(22):1930-9. PubMed ID: 11127581
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
15. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity.
Zhang YC; Powers M; Wasserfall C; Brusko T; Song S; Flotte T; Snyder RO; Potter M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick HS; Agarwal A; Ellis TM; Atkinson MA
Gene Ther; 2004 Feb; 11(3):233-40. PubMed ID: 14737082
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
[TBL] [Abstract][Full Text] [Related]
17. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses.
De BP; Heguy A; Hackett NR; Ferris B; Leopold PL; Lee J; Pierre L; Gao G; Wilson JM; Crystal RG
Mol Ther; 2006 Jan; 13(1):67-76. PubMed ID: 16260185
[TBL] [Abstract][Full Text] [Related]
18. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization.
Lee GK; Maheshri N; Kaspar B; Schaffer DV
Biotechnol Bioeng; 2005 Oct; 92(1):24-34. PubMed ID: 15937953
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer into skeletal muscle using novel AAV serotypes.
Louboutin JP; Wang L; Wilson JM
J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
[TBL] [Abstract][Full Text] [Related]
20. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
